EUVIMEDEUVIMED entdecken
Open Access

Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects

Elizabeth A Werren, Guillermo Rodriguez Bey, Purvi Majethia, Parneet Kaur, Siddaramappa J Patil, Minal V Kekatpure, Alexandra Afenjar, Leila Qebibo, Lydie Burglen, Hoda Tomoum, Florence Demurger, Christele Duborg und 11 weitere

Brain · 2024

DOI: 10.1093/brain/awae299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Elizabeth A Werren und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Seizures, Developmental Disabilities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NICHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erythrocyte membrane protein band 4.1 like 3 (EPB41L3: NM_012307.5), also known as DAL1, encodes the ubiquitously expressed, neuronally enriched 4.1B protein, part of the 4.1 superfamily of membrane-cytoskeleton adaptors. The 4.1B protein plays key roles in cell spreading, migration and cytoskeletal scaffolding that support oligodendrocyte axon adhesions essential for proper myelination. We herein describe six individuals from five unrelated families with global developmental delay, intellectual disability, seizures, hypotonia, neuroregression and delayed myelination. Exome sequencing identified biallelic variants in EPB41L3 in all affected individuals: two nonsense [c.466C>T, p.(R156*); c.2776C>T, p.(R926*)] and three frameshift [c.666delT, p.(F222Lfs*46); c.2289dupC, p.(V764Rfs*19); c.948_949delTG, p.(A317Kfs*33)]. Quantitative-real time PCR and western blot analyses of human fibroblasts harbouring EPB41L3:c.666delT, p.(F222Lfs*46) indicated ablation of EPB41L3 mRNA and 4.1B protein expression. Inhibition of the nonsense mediated decay (NMD) pathway led to an upregulation of EPB41L3:c.666delT transcripts, supporting NMD as a pathogenic mechanism. Epb41l3-deficient mouse oligodendroglia cells showed significant reduction in mRNA expression of key myelin genes, reduced branching and increased apoptosis. Our report provides the first clinical description of an autosomal recessive disorder associated with variants in EPB41L3, which we refer to as EPB41L3-associated developmental disorder (EADD). Moreover, our functional studies substantiate the pathogenicity of EPB41L3 hypothesized loss-of-function variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeizuresDevelopmental DisabilitiesHumansMaleAnimalsFemaleMiceChildChild, PreschoolMyelin SheathPedigreeAdolescentOligodendrogliaMembrane ProteinsExome Sequencing

Stichwörter der Autor:innen

4.1Bdelayed myelinationloss-of-functionneurodevelopmental disorderoligodendroglia

Substanzen

Membrane Proteins

Autor:innen und Institutionen

  • Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
  • Advanced Precision Medicine Laboratory, The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
  • Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India.
  • Division of Medical Genetics, Narayana Health-Mazumdar Shaw Medical Center, Narayana Health, Bangalore 560099, India.
  • Department of Neurology, Division of Pediatric Neurology, Mazumdar Shaw Medical Center, Narayana Health, Bangalore 560099, India.

ORCID-Profile: Henry Houlden, Reza Maroofian, Anju Shukla

Förderung

  • NINDS NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Werren, E. A., Rodriguez Bey, G., Majethia, P., Kaur, P., Patil, S. J., Kekatpure, M. V., Afenjar, A., Qebibo, L., Burglen, L., Tomoum, H., Demurger, F., Duborg, C., Siddiqui, S., Tsan, Y. C., Abdullah, U., Ali, Z., Saadi, S. M., Baig, S. M., Houlden, H., …, & Shukla, A. (2024). Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects. Brain. https://doi.org/10.1093/brain/awae299

Vancouver

Werren EA, Rodriguez Bey G, Majethia P, Kaur P, Patil SJ, Kekatpure MV, et al. Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects. Brain. 2024. doi:10.1093/brain/awae299

BibTeX
@article{Werren2024,
  author = {Werren, Elizabeth A and Rodriguez Bey, Guillermo and Majethia, Purvi and Kaur, Parneet and Patil, Siddaramappa J and Kekatpure, Minal V and Afenjar, Alexandra and Qebibo, Leila and Burglen, Lydie and Tomoum, Hoda and Demurger, Florence and Duborg, Christele and Siddiqui, Shahyan and Tsan, Yao-Chang and Abdullah, Uzma and Ali, Zafar and Saadi, Saadia Maryam and Baig, Shahid Mahmood and Houlden, Henry and Maroofian, Reza and Padiath, Quasar Saleem and Bielas, Stephanie L and Shukla, Anju},
  title = {Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae299}
}
Kostenlos starten →